Delivery Order SPE2DR25D2007-SPE2DR26FM33D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,396.08 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/mL in 100 mL bottles. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. Visipaque is a contrast medium used in medical imaging procedures, reflecting the critical role of...
- The Defense Logistics Agency awarded a $5,006.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Visipaque 320 mg/ml in 100 ml bottles. This contract, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award for pharmaceutical procurement supporting federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,475.92 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,038.55 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/mL infusion bottles (150 mL units). This firm fixed-price delivery order, awarded on August 15, 2025, represents a non-competitive set-aside procurement and will be fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Visipaque is a contrast medium used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Visipaque 320 mg/ml infusion bottles (150 ml) with a ceiling value of $1,118.40 and a firm fixed price structure. The contract is non-competitive with no set-aside designation and has an ultimate completion date of January 5, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order valued at $2,063.20 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml infusion bottles (150 ml) on August 28, 2025, with completion targeted for August 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,301.12 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units). This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,597.96 to supply Visipaque 320 mg/mL infusion bottles (150 mL) with an ultimate completion date of December 9, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Visipaque 320 mg/mL infusion bottles (150 mL units) with a ceiling value of $1,753.42. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to be completed by November 6, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,337.80 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of October 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's medical supply procurement needs. This...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM33DDelivery Order
The Defense Logistics Agency awarded a $3,379.74 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Visipaque 320 mg/ml in 100ml bottles, with completion scheduled for January 5, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Visipaque is a contrast agent used in medical imaging procedures, representing part of the broader pharmaceutical and medical supply portfolio that AmerisourceBergen provides to federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen supplies a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support defense and federal medical procurement needs globally. The company's federal contract awards demonstrate extensive experience fulfilling diverse medical supply requirements through open competition, positioning it as a key provider for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/1/26 |